I am not totally serious but I hate always backing into deals. So I would love to see a list of on going trials and their status and what is being done to promote said trials.
I also would love to know the strategy of our trials. Are we looking to partner with other companies or impress the FDA. I thought we wanted make sure the dose was 700 and then get readings to other companies to partner with. I don't think we have the money for an approval from the FDA. An overall strategy would be nice.
So the trial in 2024: VANCOUVER, Washington, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"

, a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it has received clearance from the FDA to commence its Phase II oncology trial. The study will evaluate the efficacy of leronlimab in patients with relapsed/refractory microsatellite stable colorectal cancer (“CRC”).